FDA-approved medications only (including Wegovy®, Zepbound®, phentermine, ect.)
Monthly visits during medication initiation or dose changes
Every 3 months once on a stable dose
Additional visits only if medically indicated
The Foundations tier uses FDA-approved, brand-name weight-loss medications, prescribed on-label and according to established medical criteria.
Adults with:
BMI ≥ 30 kg/m² (obesity), or
BMI ≥ 27 kg/m² (overweight) with at least one weight-related comorbid condition (commonly listed examples include hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, etc.).
Depending on eligibility and medical history, medications may include:
Wegovy® (semaglutide)
Zepbound® (tirzepatide)
Phentermine (when appropriate and medically indicated)
Other FDA-approved anti-obesity medications, selected case-by-case
Medication selection is individualized and based on:
On-label prescribing criteria
Medical history and current conditions
Blood pressure and heart rate
Prior response or intolerance to medications
Side-effect risk and contraindications
Not every patient qualifies for every medication, and no medication is guaranteed.
Patients are seen monthly
This applies when starting or adjusting:
Wegovy®
Zepbound®
Phentermine or other approved medications
Monthly visits focus on:
Medication response and tolerability
Side-effect monitoring
Vital signs and safety review
Dose adjustments when appropriate
Monthly visits continue only until a stable, effective dose is reached.
Follow-up transitions to every 3 months
Maintenance visits focus on:
Ongoing safety and medical appropriateness
Weight and metabolic trend review
Continued need for Wegovy®, Zepbound®, phentermine, or other therapy
Reinforcement of nutrition and activity basics
Additional visits are not routine and are scheduled only if medically necessary.
Initial in-person visit and labs see labs page
You are seen once per month while starting or adjusting Wegovy®, Zepbound®, phentermine, or other approved medications.
After reaching a stable dose, visits move to once every 3 months.
Continued prescribing and monitoring as long as the medication remains safe, appropriate, and effective.
How often will I see the doctor?
Monthly visits while starting or adjusting medication
Every 3 months once you are stable
Why aren’t visits more frequent once I’m stable?
For patients on a stable dose of Wegovy®, Zepbound®, or phentermine, more frequent visits do not improve outcomes and are not medically necessary.
Can I request extra visits?
Additional visits may be scheduled for side effects, safety concerns, or medical issues. Routine extra visits are not part of the Foundations tier.
